Literature DB >> 11096484

Lutetium Texaphyrin: A New Therapeutic Tool for Human Atherosclerosis.

.   

Abstract

Entities:  

Year:  1999        PMID： 11096484     DOI： 10.1007/s11936-999-0035-3

Source DB:  PubMed          Journal:  Curr Treat Options Cardiovasc Med        ISSN： 1092-8464


× No keyword cloud information.
  6 in total

Review 1.  How does photodynamic therapy work?

Authors:  B W Henderson; T J Dougherty
Journal:  Photochem Photobiol       Date:  1992-01       Impact factor: 3.421

2.  Lutetium texaphyrin (PCI-0123): a near-infrared, water-soluble photosensitizer.

Authors:  S W Young; K W Woodburn; M Wright; T D Mody; Q Fan; J L Sessler; W C Dow; R A Miller
Journal:  Photochem Photobiol       Date:  1996-06       Impact factor: 3.421

3.  Localization and efficacy analysis of the phototherapeutic lutetium texaphyrin (PCI-0123) in the murine EMT6 sarcoma model.

Authors:  K W Woodburn; Q Fan; D R Miles; D Kessel; Y Luo; S W Young
Journal:  Photochem Photobiol       Date:  1997-03       Impact factor: 3.421

Review 4.  Biodistribution of photosensitizing agents.

Authors:  D Kessel; K Woodburn
Journal:  Int J Biochem       Date:  1993-10

5.  Phototherapy of cancer and atheromatous plaque with texaphyrins.

Authors:  K W Woodburn; Q Fan; D Kessel; M Wright; T D Mody; G Hemmi; D Magda; J L Sessler; W C Dow; R A Miller; S W Young
Journal:  J Clin Laser Med Surg       Date:  1996-10

6.  Identification of singlet oxygen as the cytotoxic agent in photoinactivation of a murine tumor.

Authors:  K R Weishaupt; C J Gomer; T J Dougherty
Journal:  Cancer Res       Date:  1976-07       Impact factor: 12.701
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.